Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities-Reference-Cited by-同舟云学术

Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities

Published:2023-07-24 Issue:8 Volume:30 Page:1160-1171
ISSN:1545-9993
Container-title:Nature Structural & Molecular Biology
language:en
Short-container-title:Nat Struct Mol Biol

Author:

Zhang Yuxiang,Remillard David,Onubogu Ugoma,Karakyriakou Barbara^ORCID,Asiaban Joshua N.,Ramos Anissa R.,Bowland Kirsten^ORCID,Bishop Timothy R.,Barta Paige A.,Nance Stephanie,Durbin Adam D.^ORCID,Ott Christopher J.^ORCID,Janiszewska Michalina^ORCID,Cravatt Benjamin F.,Erb Michael A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Structural Biology

Link

https://www.nature.com/articles/s41594-023-01041-4.pdf

Reference97 articles.

1. Shortt, J., Ott, C. J., Johnstone, R. W. & Bradner, J. E. A chemical probe toolbox for dissecting the cancer epigenome. Nat. Rev. Cancer 17, 160–183 (2017).

2. Chang, L., Ruiz, P., Ito, T. & Sellers, W. R. Targeting pan-essential genes in cancer: challenges and opportunities. Cancer Cell. 39, 466–479 (2021).

3. Seto, E. & Yoshida, M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb. Perspect. Biol. 6, a018713–a018713 (2014).

4. Bachy, E. et al. Final analysis of the Ro-CHOP Phase III Study (Conducted by LYSA): romidepsin plus CHOP in patients with peripheral T-cell lymphoma. Blood 136, 32–33 (2020).

5. Falkenberg, K. J. & Johnstone, R. W. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat. Rev. Drug Discov. 13, 673–691 (2014).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The fork remodeler helicase-like transcription factor in cancer development: all at once;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. Mapping Genetic Interactions of All Paralogs in the Human Genome;2024-07-19

3. Pharmacological targeting of the cancer epigenome;Nature Cancer;2024-06-27

4. Developmental origins shape the paediatric cancer genome;Nature Reviews Cancer;2024-05-02

5. Chemical-genetics refines transcription factor regulatory circuits;Trends in Cancer;2024-01